Ordering
Available Variants1 mg
CHA.97189-1mg
Price
€68.96
Available – Dispatch in 14 days
5 mg
CHA.97189-5mg
Price
€159.80
Available – Dispatch in 14 days
100 mg
CHA.97189-100mg
Price
€175.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 mg | CHA.97189-1mg | €68.96 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.97189-5mg | €159.80 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHA.97189-100mg | €175.20 |
phyproof® Reference Substance
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C20H26N2O2 |
|---|---|
| CAS Number | 522-66-7 |
| Molecular Weight | 326.43 |
| NACRES | NA.24 |
| UNSPSC Code | 41116107 |
| Beilstein/REAXYS Number | 91444 |
| MDL number | MFCD00151107 |
Safety Information Handling visibility
| pictograms |
GHS08
GHS07
  GHS08,GHS07
|
|---|---|
| signalword | Danger |
| hcodes | H315,H317,H319,H334,H335 |
| pcodes | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Classifications | Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 |
| target_organs | Respiratory system |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
(-)-Dihydroquinine, with a CAS number of 101622-51-9, is a synthetic compound that has garnered significant attention in the scientific community due to its potential therapeutic applications. As a derivative of quinine, it exhibits a range of biological activities, including antimalarial and anti-inflammatory properties. The compounds mechanism of action involves the interference with various cellular processes, ultimately leading to the inhibition of parasite growth and the modulation of immune responses. Researchers have been exploring the potential of (-)-Dihydroquinine as a treatment for various diseases, including malaria and other infectious disorders. Further studies are necessary to fully elucidate the compounds pharmacological profile and to determine its efficacy and safety in clinical settings, which could lead to the development of novel therapeutic strategies. Its unique properties make it an interesting candidate for ongoing research and development efforts.
